Treatment-failure tularemia in children
Arzu Karlı (Karlı A), Gülnar Şensoy (Şensoy G), Şule Paksu (Paksu Ş), Muhammet Furkan Korkmaz (Korkmaz MF), Ömer Ertuğrul (Ertuğrul Ö), Rıfat Karlı (Karlı R)
Clin Exp Pediatr. 2018;61(2):49-52.   Published online 2018 Feb 28     DOI: https://doi.org/10.3345/kjp.2018.61.2.49
Citations to this article as recorded by Crossref logo
Tularemia treatment: experimental and clinical data
Max Maurin, Léa Pondérand, Aurélie Hennebique, Isabelle Pelloux, Sandrine Boisset, Yvan Caspar
Frontiers in Microbiology.2024;[Epub]     CrossRef
Tick-borne tularemia in a four-year-old girl
Eva Vávrová, Lukáš Homola, Vlastirad Mach, Jana Lindušková, Lenka Krbková
Česko-slovenská pediatrie.2023; 78(Suppl.1): 20.     CrossRef
Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia
Mark M. Hahn, Cheryl A. Triplett, Michael S. Anderson, Jennifer I. Smart, Karine Litherland, Stephen Keech, Franziska von Siebenthal, Mark Jones, Andrew J. Phipps, Lisa N. Henning
Antibiotics.2023; 12(8): 1337.     CrossRef
Francisella tularensis caused cervical lymphadenopathy in little children after a tick bite: Two case reports and a short literature review
Rudolf Kukla, Renata Kračmarová, Lenka Ryšková, Jan Bavlovič, Věra Pellantová, Radka Bolehovská, Miroslav Fajfr, Ivo Pavlík, Pavel Boštík
Ticks and Tick-borne Diseases.2022; 13(2): 101893.     CrossRef
Skin involvement in Francisella tularensis infection: a case report of two clinical cases
Maja Prah, Ana Kenk, Jana Rejc Marko
Acta Dermatovenerologica Alpina Pannonica et Adria.2022;[Epub]     CrossRef
Pediatric Tularemia—A Case Series From a Single Center in Switzerland
Nina Schöbi, Philipp K A Agyeman, Andrea Duppenthaler, Andreas Bartenstein, Peter M Keller, Franziska Suter-Riniker, Kristina M Schmidt, Matthias V Kopp, Christoph Aebi
Open Forum Infectious Diseases.2022;[Epub]     CrossRef
Paediatric oropharyngeal tularaemia requiring surgical intervention
Amina Nemmour, Adzreil Bakri, Claude A Fischer, Yves Brand
BMJ Case Reports.2019; 12(9): e229754.     CrossRef
A novel vaccine platform using glucan particles for induction of protective responses againstFrancisella tularensisand other pathogens
A Abraham, G Ostroff, S M Levitz, P C F Oyston
Clinical and Experimental Immunology.2019; 198(2): 143.     CrossRef